Conference Coverage

Ask depressed patients about hypersomnia to screen for mixicity

Publish date: November 9, 2018

 

REPORTING FROM THE ECNP CONGRESS

The BRIDGE-II-MIX study was sponsored by Sanofi-Aventis. Dr. Murru reported having no financial conflicts of interest regarding the study.

Pages

Recommended Reading

FDA panels vote no on opioid-containing drug for MDD
MDedge Psychiatry
Interacting with horses helps veterans with PTSD; Identical twin battles anorexia
MDedge Psychiatry
Four predictors confirmed for treatment-resistant depression
MDedge Psychiatry
FDA panels back brexanolone infusion for postpartum depression
MDedge Psychiatry
Childhood abuse linked with tripled adult SLE incidence
MDedge Psychiatry
Novel theory explains SSRIs’ variable efficacy
MDedge Psychiatry
Identifying and stopping a likely mass shooter: A case study
MDedge Psychiatry
Lay counseling effective for reducing late-life depression
MDedge Psychiatry
Physical activity tied to lower depression risk among older adults
MDedge Psychiatry
Higher prenatal exposure to daylight tied to lower depression risk
MDedge Psychiatry